After being the epicenter of a devastating second wave, India’s wealthiest state is already taking steps to prepare for a possible third wave, according to its tourism and environment minister. The western state of Maharashtra, home to India’s financial capital Mumbai, has so far reported more than 5.4 million cases, including over 82,000 deaths from… Read More »
A patient arrives at the Emergency entrance to Maimonides Medical Center, as the spread of the coronavirus disease (COVID-19) continues, in the Borough Park neighborhood of Brooklyn, New York, U.S., October 14, 2020. Brendan McDermid | Reuters Colder temperatures are arriving in the Northern Hemisphere, and an insidious rise in new coronavirus cases in the… Read More »
Independent research experts iReach have released findings from a survey they carried out prior to the COVID-19 restrictions in Ireland. The survey, which was carried out on behalf of leading protection specialist Royal London, asked over 1,000 adults nationwide if they exercised regularly and if so, how often. 33% of respondents said they did in… Read More »
Sept. 28, 2018 — The FDA has approved the third of a new type of drug to prevent migraine headaches in adults. Galcanezumab-gnlm (Emgality) targets calcitonin gene-related peptide (CGRP), a molecule that’s produced in nerve cells of the brain and spinal cord. The FDA approved two other CGRP drugs for migraine — erenumab (Aimovig) and fremanezumab-vfrm… Read More »